Search

Your search keyword '"Boehme C"' showing total 18 results
Start Over Author "Boehme C" Publication Type Electronic Resources
18 results on '"Boehme C"'

1. Gait and postural disorders in parkinsonism: a clinical approach

Author

Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., Wenning, G.K., Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., and Wenning, G.K.

Abstract

Contains fulltext : 229737.pdf (Publisher’s version ) (Open Access), Disturbances of balance, gait and posture are a hallmark of parkinsonian syndromes. Recognition of these axial features can provide important and often early clues to the nature of the underlying disorder, and, therefore, help to disentangle Parkinson's disease from vascular parkinsonism and various forms of atypical parkinsonism, including multiple system atrophy, progressive supranuclear palsy, and corticobasal syndrome. Careful assessment of axial features is also essential for initiating appropriate treatment strategies and for documenting the outcome of such interventions. In this article, we provide an overview of balance, gait and postural impairment in parkinsonian disorders, focusing on differential diagnostic aspects.

Published
2020

2. Gait and postural disorders in parkinsonism: a clinical approach

Author

Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., Wenning, G.K., Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., and Wenning, G.K.

Abstract

Contains fulltext : 229737.pdf (Publisher’s version ) (Open Access), Disturbances of balance, gait and posture are a hallmark of parkinsonian syndromes. Recognition of these axial features can provide important and often early clues to the nature of the underlying disorder, and, therefore, help to disentangle Parkinson's disease from vascular parkinsonism and various forms of atypical parkinsonism, including multiple system atrophy, progressive supranuclear palsy, and corticobasal syndrome. Careful assessment of axial features is also essential for initiating appropriate treatment strategies and for documenting the outcome of such interventions. In this article, we provide an overview of balance, gait and postural impairment in parkinsonian disorders, focusing on differential diagnostic aspects.

Published
2020

3. Gait and postural disorders in parkinsonism: a clinical approach

Author

Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., Wenning, G.K., Raccagni, C., Nonnekes, J.H., Bloem, B.R., Peball, M., Boehme, C., Seppi, K., and Wenning, G.K.

Abstract

Contains fulltext : 229737.pdf (Publisher’s version ) (Open Access), Disturbances of balance, gait and posture are a hallmark of parkinsonian syndromes. Recognition of these axial features can provide important and often early clues to the nature of the underlying disorder, and, therefore, help to disentangle Parkinson's disease from vascular parkinsonism and various forms of atypical parkinsonism, including multiple system atrophy, progressive supranuclear palsy, and corticobasal syndrome. Careful assessment of axial features is also essential for initiating appropriate treatment strategies and for documenting the outcome of such interventions. In this article, we provide an overview of balance, gait and postural impairment in parkinsonian disorders, focusing on differential diagnostic aspects.

Published
2020

4. Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Author

Reid, M.J.A. (Michael J A), Arinaminpathy, N. (Nimalan), Bloom, A. (Amy), Bloom, B.R. (Barry R), Boehme, C. (Catharina), Chaisson, R. (Richard), Chin, D.P. (Daniel P), Churchyard, G. (Gavin), Cox, H. (Helen), Ditiu, L. (Lucica), Dybul, M. (Mark), Farrar, J. (Jeremy), Fauci, A.S. (Anthony S), Fekadu, E. (Endalkachew), Fujiwara, P.I. (Paula I), Hallett, T.B. (Timothy), Hanson, C.L. (Christy L), Harrington, M. (Mark), Herbert, N. (Nick), Hopewell, P.C. (Philip C), Ikeda, C. (Chieko), Jamison, D.T. (Dean T), Khan, A.J. (Aamir J), Koek, I. (Irene), Krishnan, N. (Nalini), Motsoaledi, A. (Aaron), Pai, M. (Madhukar), Raviglione, M.C. (Mario C), Sharman, A. (Almaz), Small, P.M. (Peter M), Swaminathan, S. (Soumya), Temesgen, Z. (Zelalem), Vassall, A. (Anna), Venkatesan, N. (Nandita), van Weezenbeek, K. (Kitty), Yamey, G. (Gavin), Agins, B.D. (Bruce D), Alexandru, S. (Sofia), Andrews, J.R. (Jason R), Beyeler, N. (Naomi), Bivol, S. (Stela), Brigden, G. (Grania), Cattamanchi, A. (Adithya), Cazabon, D. (Danielle), Crudu, V. (Valeriu), Daftary, A. (Amrita), Dewan, P. (Puneet), Doepel, L.K. (Laurie K), Eisinger, R.W. (Robert W), Fan, V. (Victoria), Fewer, S. (Sara), Furin, J. (Jennifer), Goldhaber-Fiebert, J.D. (Jeremy D), Gomez, G.B. (Gabriela B), Graham, S.M. (Stephen M), Gupta, D. (Devesh), Kamene, M. (Maureen), Khaparde, S. (Sunil), Mailu, E.W. (Eunice W), Masini, E.O. (Enos O), McHugh, L. (Lorrie), Mitchell, E.M.H. (Ellen), Moon, S. (Suerie), Osberg, M. (Michael), Pande, T. (Tripti), Prince, L. (Lea), Rade, K. (Kirankumar), Rao, R. (Raghuram), Remme, M. (Michelle), Seddon, J.A. (James A), Selwyn, C. (Casey), Shete, P. (Priya), Sachdeva, K.S. (Kuldeep S), Stallworthy, G. (Guy), Vesga, J.F. (Juan F), Vilc, V. (Valentina), Goosby, E.P. (Eric P), Reid, M.J.A. (Michael J A), Arinaminpathy, N. (Nimalan), Bloom, A. (Amy), Bloom, B.R. (Barry R), Boehme, C. (Catharina), Chaisson, R. (Richard), Chin, D.P. (Daniel P), Churchyard, G. (Gavin), Cox, H. (Helen), Ditiu, L. (Lucica), Dybul, M. (Mark), Farrar, J. (Jeremy), Fauci, A.S. (Anthony S), Fekadu, E. (Endalkachew), Fujiwara, P.I. (Paula I), Hallett, T.B. (Timothy), Hanson, C.L. (Christy L), Harrington, M. (Mark), Herbert, N. (Nick), Hopewell, P.C. (Philip C), Ikeda, C. (Chieko), Jamison, D.T. (Dean T), Khan, A.J. (Aamir J), Koek, I. (Irene), Krishnan, N. (Nalini), Motsoaledi, A. (Aaron), Pai, M. (Madhukar), Raviglione, M.C. (Mario C), Sharman, A. (Almaz), Small, P.M. (Peter M), Swaminathan, S. (Soumya), Temesgen, Z. (Zelalem), Vassall, A. (Anna), Venkatesan, N. (Nandita), van Weezenbeek, K. (Kitty), Yamey, G. (Gavin), Agins, B.D. (Bruce D), Alexandru, S. (Sofia), Andrews, J.R. (Jason R), Beyeler, N. (Naomi), Bivol, S. (Stela), Brigden, G. (Grania), Cattamanchi, A. (Adithya), Cazabon, D. (Danielle), Crudu, V. (Valeriu), Daftary, A. (Amrita), Dewan, P. (Puneet), Doepel, L.K. (Laurie K), Eisinger, R.W. (Robert W), Fan, V. (Victoria), Fewer, S. (Sara), Furin, J. (Jennifer), Goldhaber-Fiebert, J.D. (Jeremy D), Gomez, G.B. (Gabriela B), Graham, S.M. (Stephen M), Gupta, D. (Devesh), Kamene, M. (Maureen), Khaparde, S. (Sunil), Mailu, E.W. (Eunice W), Masini, E.O. (Enos O), McHugh, L. (Lorrie), Mitchell, E.M.H. (Ellen), Moon, S. (Suerie), Osberg, M. (Michael), Pande, T. (Tripti), Prince, L. (Lea), Rade, K. (Kirankumar), Rao, R. (Raghuram), Remme, M. (Michelle), Seddon, J.A. (James A), Selwyn, C. (Casey), Shete, P. (Priya), Sachdeva, K.S. (Kuldeep S), Stallworthy, G. (Guy), Vesga, J.F. (Juan F), Vilc, V. (Valentina), and Goosby, E.P. (Eric P)

Abstract

___Key messages___ The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation. These investments are designed to fulfil the mandate of the UN High Level Meeting on tuberculosis. In addition, they answer t

Published
2019
Full Text
View/download PDF

5. Lutetium-177-PSMA radioligand therapy. Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Dusseldorf, Essen, and Cologne and the MDK Nordrhein

Author

Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B., Essler, M., Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B., and Essler, M.

Abstract

In the last 3 years, Lutetium-177 prostate-specific membrane antigen radioligand therapy (Lu-177-PSMA-RLT) has received increasing attention in nuclear medicine as a new form of treatment for castration-resistant metastatic prostate cancer. This therapy combines the radionuclide Lutetium-177, which has been therapeutically used in nuclear medicine for many years, with a molecular target of the transmembrane prostate-specific membrane antigen expressed by prostate cancer cells. Since there are no prospective randomized studies on Lu-177-PSMA-RLT and the question of reimbursement has repeatedly been the subject of review by the MDK Nordrhein (Medischenische Dienst der Krankenversicherung), there was a desire because of the increasing number of patients being treated to clarify under which circumstances Lu-177-PSMA-RLT can be reimbursed by German statutory health insurance. The goals of this article are to help treating physicians understand how this new therapy option works, to integrate it in the overall therapy concept for castration-resistant metastatic prostate cancer, and, above all, to use Lu-177-PSMA-RLT-based on the current data-at the right place in the therapy sequence of castration-resistant metastatic prostate cancer.

Published
2018

6. Lutetium-177-PSMA radioligand therapy. Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Dusseldorf, Essen, and Cologne and the MDK Nordrhein

Author

Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B., Essler, M., Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B., and Essler, M.

Abstract

In the last 3 years, Lutetium-177 prostate-specific membrane antigen radioligand therapy (Lu-177-PSMA-RLT) has received increasing attention in nuclear medicine as a new form of treatment for castration-resistant metastatic prostate cancer. This therapy combines the radionuclide Lutetium-177, which has been therapeutically used in nuclear medicine for many years, with a molecular target of the transmembrane prostate-specific membrane antigen expressed by prostate cancer cells. Since there are no prospective randomized studies on Lu-177-PSMA-RLT and the question of reimbursement has repeatedly been the subject of review by the MDK Nordrhein (Medischenische Dienst der Krankenversicherung), there was a desire because of the increasing number of patients being treated to clarify under which circumstances Lu-177-PSMA-RLT can be reimbursed by German statutory health insurance. The goals of this article are to help treating physicians understand how this new therapy option works, to integrate it in the overall therapy concept for castration-resistant metastatic prostate cancer, and, above all, to use Lu-177-PSMA-RLT-based on the current data-at the right place in the therapy sequence of castration-resistant metastatic prostate cancer.

Published
2018

9. How to Reach a Thousand-Second in-Plane Polarization Lifetime with 0.97-GeV/c Deuterons in a Storage Ring

Author

Guidoboni, G., Stephenson, E., Andrianov, S., Augustyniak, W., Bagdasarian, Z., Bai, M., Baylac, M., Bernreuther, W., Bertelli, S., Berz, M., Boeker, J., Boehme, C., Bsaisou, J., Chekmenev, S., Chiladze, D., Ciullo, G., Contalbrigo, M., de Conto, J. -M, Dymov, S., Engels, R., Esser, F. M., Eversmann, D., Felden, O., Gaisser, M., Gebel, R., Glueckler, H., Goldenbaum, F., Grigoryev, K., Grzonka, D., Hahnraths, T., Heberling, D., Hejny, V., Hempelmann, N., Hetze, J., Hinder, F., Hipple, R., Hoelscher, D., Ivanov, A., Kacharava, A., Kamerdzhiev, V., Kamys, B., Keshelashvili, I., Khoukaz, A., Koop, I., Krause, H. -J, Krewald, S., Kulikov, A., Lehrach, A., Lenisa, P., Lomidze, N., Lorentz, B., Maanen, P., macharashvili, G., Magiera, A., Maier, R., Iviakino, K., Marianski, B., Mchedlishvili, D., Meissner, Ulf-G., Mey, S., Morse, W., Mueller, F., Nass, A., Natour, G., Nikolaev, N., Nioradze, M., Nowakowski, K., Orlov, Y., Pesce, A., Prasuhn, D., Pretz, J., Rathmann, F., Ritman, J., Rosenthal, M., Rudy, Z., Saleev, A., Sefzick, T., Senriertzidis, Y., Senichev, Y., Shmakova, V., Silenko, A., Simon, M., Slim, J., Soltner, H., Stah, A., Stassen, R., Statera, M., Stockhorst, H., Straatmann, H., Stroeher, H., Tabidze, M., Talman, R., Engblom Thorngren, Pia, Trinke, F., Trzcinski, A., Uzikov, Yu., Valdati, Yu., Valetov, E., Vassiliev, A., Weidemann, C., Wilkin, C., Wronska, A., Wuestner, P., Zakrzewska, M., Zupranski, P., Zyuzin, D., Guidoboni, G., Stephenson, E., Andrianov, S., Augustyniak, W., Bagdasarian, Z., Bai, M., Baylac, M., Bernreuther, W., Bertelli, S., Berz, M., Boeker, J., Boehme, C., Bsaisou, J., Chekmenev, S., Chiladze, D., Ciullo, G., Contalbrigo, M., de Conto, J. -M, Dymov, S., Engels, R., Esser, F. M., Eversmann, D., Felden, O., Gaisser, M., Gebel, R., Glueckler, H., Goldenbaum, F., Grigoryev, K., Grzonka, D., Hahnraths, T., Heberling, D., Hejny, V., Hempelmann, N., Hetze, J., Hinder, F., Hipple, R., Hoelscher, D., Ivanov, A., Kacharava, A., Kamerdzhiev, V., Kamys, B., Keshelashvili, I., Khoukaz, A., Koop, I., Krause, H. -J, Krewald, S., Kulikov, A., Lehrach, A., Lenisa, P., Lomidze, N., Lorentz, B., Maanen, P., macharashvili, G., Magiera, A., Maier, R., Iviakino, K., Marianski, B., Mchedlishvili, D., Meissner, Ulf-G., Mey, S., Morse, W., Mueller, F., Nass, A., Natour, G., Nikolaev, N., Nioradze, M., Nowakowski, K., Orlov, Y., Pesce, A., Prasuhn, D., Pretz, J., Rathmann, F., Ritman, J., Rosenthal, M., Rudy, Z., Saleev, A., Sefzick, T., Senriertzidis, Y., Senichev, Y., Shmakova, V., Silenko, A., Simon, M., Slim, J., Soltner, H., Stah, A., Stassen, R., Statera, M., Stockhorst, H., Straatmann, H., Stroeher, H., Tabidze, M., Talman, R., Engblom Thorngren, Pia, Trinke, F., Trzcinski, A., Uzikov, Yu., Valdati, Yu., Valetov, E., Vassiliev, A., Weidemann, C., Wilkin, C., Wronska, A., Wuestner, P., Zakrzewska, M., Zupranski, P., and Zyuzin, D.

Abstract

We observe a deuteron beam polarization lifetime near 1000 s in the horizontal plane of a magnetic storage ring (COSY). This long spin coherence time is maintained through a combination of beam bunching, electron cooling, sextupole field corrections, and the suppression of collective effects through beam current limits. This record lifetime is required for a storage ring search for an intrinsic electric dipole moment on the deuteron at a statistical sensitivity level approaching 10(-29) e cm., QC 20161005

Published
2016
Full Text
View/download PDF

10. Using coherent dynamics to quantify spin coupling within triplet-exciton/polaron complexes in organic diodes

Author

Baker, WJ, Keevers, TL, Boehme, C, McCamey, DR, Baker, WJ, Keevers, TL, Boehme, C, and McCamey, DR

Abstract

Quantifying the spin-spin interactions which influence electronic transitions in organic semiconductors is crucial for understanding their magneto-optoelectronic properties. By combining a theoretical model for three spin interactions in the coherent regime with pulsed electrically detected magnetic resonance experiments on π-conjugated polymer diodes (poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene]), we quantify the spin coupling within complexes comprising three spin-1/2 particles. We determine that these particles form triplet-exciton/polaron pairs, where the polaron-exciton exchange is over five orders of magnitude weaker (<170 MHz) than that within the exciton. This approach provides a direct spectroscopic approach for distinguishing between coupling regimes, and to test hypotheses relating microscopic properties to bulk characteristics of organic electronic devices.

Published
2015

13. High-Field Phenomena of Qubits

Author

Tol, Johan, Tol, Johan, Morley, G. W., Takahashi, S., McCamey, D. R., Boehme, C., Zvanut, M. E., Tol, Johan, Tol, Johan, Morley, G. W., Takahashi, S., McCamey, D. R., Boehme, C., and Zvanut, M. E.

Abstract

Electron and nuclear spins are very promising candidates to serve as quantum bits (qubits) for proposed quantum computers, as the spin degrees of freedom are relatively isolated from their surroundings and can be coherently manipulated, e.g., through pulsed electron paramagnetic resonance (EPR) and nuclear magnetic resonance (NMR). For solid-state spin systems, impurities in crystals based on carbon and silicon in various forms have been suggested as qubits, and very long relaxation rates have been observed in such systems. We have investigated a variety of these systems at high magnetic fields in our multifrequency pulsed EPR/ENDOR (electron nuclear double resonance) spectrometer. A high magnetic field leads to large electron spin polarizations at helium temperatures, giving rise to various phenomena that are of interest with respect to quantum computing. For example, it allows the initialization of both the electron spin as well as hyperfine-coupled nuclear spins in a well-defined state by combining millimeter and radio-frequency radiation. It can increase the T 2 relaxation times by eliminating decoherence due to dipolar interaction and lead to new mechanisms for the coherent electrical readout of electron spins. We will show some examples of these and other effects in Si:P, SiC:N and nitrogen-related centers in diamond.

Published
2009

14. High-Field Phenomena of Qubits

Author

Tol, Johan, Tol, Johan, Morley, G. W., Takahashi, S., McCamey, D. R., Boehme, C., Zvanut, M. E., Tol, Johan, Tol, Johan, Morley, G. W., Takahashi, S., McCamey, D. R., Boehme, C., and Zvanut, M. E.

Abstract

Electron and nuclear spins are very promising candidates to serve as quantum bits (qubits) for proposed quantum computers, as the spin degrees of freedom are relatively isolated from their surroundings and can be coherently manipulated, e.g., through pulsed electron paramagnetic resonance (EPR) and nuclear magnetic resonance (NMR). For solid-state spin systems, impurities in crystals based on carbon and silicon in various forms have been suggested as qubits, and very long relaxation rates have been observed in such systems. We have investigated a variety of these systems at high magnetic fields in our multifrequency pulsed EPR/ENDOR (electron nuclear double resonance) spectrometer. A high magnetic field leads to large electron spin polarizations at helium temperatures, giving rise to various phenomena that are of interest with respect to quantum computing. For example, it allows the initialization of both the electron spin as well as hyperfine-coupled nuclear spins in a well-defined state by combining millimeter and radio-frequency radiation. It can increase the T 2 relaxation times by eliminating decoherence due to dipolar interaction and lead to new mechanisms for the coherent electrical readout of electron spins. We will show some examples of these and other effects in Si:P, SiC:N and nitrogen-related centers in diamond.

Published
2009

15. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study

Author

Ruhstaller, T, von Moos, R, Rufibach, K, Ribi, K, Glaus, A, Spaeti, B, Koeberle, D, Mueller, U, Hoefliger, M, Hess, D, Boehme, C, Thuerlimann, B, Ruhstaller, T, von Moos, R, Rufibach, K, Ribi, K, Glaus, A, Spaeti, B, Koeberle, D, Mueller, U, Hoefliger, M, Hess, D, Boehme, C, and Thuerlimann, B

Abstract

OBJECTIVES: The purpose of this investigation was firstly to assess the overall frequency of subjectively experienced symptoms self-reported by patients receiving endocrine therapy and secondly to compare these symptoms with side effects assessed by clinicians in pivotal trials. METHODS: Unselected patients with early and advanced breast cancer receiving endocrine therapy were approached consecutively during a routine outpatient visit. They received a questionnaire called Checklist for Patients with Endocrine Therapy (C-PET), a validated self-assessment tool to determine prespecified symptoms associated with endocrine therapy. Data on toxicity were also obtained from previously published trials. RESULTS: 405 patients were approached and 373 agreed to participate in this study. Some symptoms were significantly more often recorded by the women in the adjuvant setting completing the C-PET than by physicians' reports in pivotal trials: hot flushes/sweats (C-PET 70%, ATAC 40% and BIG1-98 38%), low energy (C-PET 45%, ATAC 15% and BIG1-98 9%), fluid retention (C-PET 22% and BIG1-98 7%) and vaginal dryness (C-PET 30% and BIG1-98 3%). Similar differences were observed in the metastatic and adjuvant setting. CONCLUSIONS: A simple tool like the C-PET questionnaire is able to reflect the treatment burden of endocrine therapies and may be helpful to improve communication between patients and care providers. Some symptoms were significantly more often reported by the women in the C-PET than by physicians in pivotal trials.

Published
2009

18. An Appeal to the Global Health Community for a Tripartite Innovation: An 'essential Diagnostics List,' 'health in All Policies,' and 'see-Through 21st Century Science and Ethics'

Author

Dove, E.S., Barlas, O., Birch, K., Boehme, C., Borda-Rodriguez, A., Byne, W.M., Chaverneff, F., Coskun, Y., Dahl, M.-L., Dereli, T., Diwakar, S., Elbeyli, L., Endrenyi, L., Eroʇlu-Kesim, B., Ferguson, L.R., Gungor, K., Gursoy, U., Hekim, F., Huzair, F., Kaushik, K., Kickbusch, I., Klroʇlu, O., Kolker, E., Kononen, E., Lin, B., Llerena, A., Malhan, F., Nair, B., Patrinos, G.P., Sardas, S., Sert, O., Srivastava, S., Steuten, L.M.G., Toraman, C., Vayena, E., Wang, Wei, Warnich, L., Ozdemir, V., Dove, E.S., Barlas, O., Birch, K., Boehme, C., Borda-Rodriguez, A., Byne, W.M., Chaverneff, F., Coskun, Y., Dahl, M.-L., Dereli, T., Diwakar, S., Elbeyli, L., Endrenyi, L., Eroʇlu-Kesim, B., Ferguson, L.R., Gungor, K., Gursoy, U., Hekim, F., Huzair, F., Kaushik, K., Kickbusch, I., Klroʇlu, O., Kolker, E., Kononen, E., Lin, B., Llerena, A., Malhan, F., Nair, B., Patrinos, G.P., Sardas, S., Sert, O., Srivastava, S., Steuten, L.M.G., Toraman, C., Vayena, E., Wang, Wei, Warnich, L., and Ozdemir, V.

Abstract

Dove, E.S., Barlas, Ö., Birch, K., Boehme, C., Borda-Rodriguez, A., Byne, W.M., Chaverneff, F., Coşkun, Y., Dahl, M.-L., Dereli, T., Diwakar, S., Elbeyli, L., Endrenyi, L., Eroʇlu-Kesim, B., Ferguson, L.R., Güngör, K., Gürsoy, U., Hekim, N., Huzair, F., Kaushik, K., Kickbusch, I., Klroʇlu, O., Kolker, E., Könönen, E., Lin, B., Llerena, A., Malhan, F., Nair, B., Patrinos, G.P., Sardaş, S., Sert, O., Srivastava, S., Steuten, L.M.G., Toraman, C., Vayena, E., Wang, W., Warnich, L., Özdemir, V. (2015). An Appeal to the Global Health Community for a Tripartite Innovation: An "essential Diagnostics List," "health in All Policies," and "see-Through 21st Century Science and Ethics". In OMICS A Journal of Integrative Biology, 19(8), 435-442. Available here.

Catalog

Books, media, physical & digital resources
See catalog results